Myleran Tablet, Film Coated
Product Images NDC 80725-620
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Myleran (NDC 80725-620). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Waylis Therapeutics Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Waylis Logo (Myleran 2)
Carton (Myleran 4)
MYLERAN® is a drug that consists of 2mg tablets containing busulfan. It is essential to take the drug only with medical supervision and is not recommended to take in larger doses or for a longer time than directed by the physician. Periodic blood counts are needed to decide the accurate dose. The tablets should be stored at a controlled room temperature of 25°C and can be dispensed in tight containers. The package insert should be consulted for dosage and administration. The tablets are distributed by Waylis Therapeutics LLC, and are made in Germany.*
Label (Myleran 5)
Storeat25° (77 evcursions 25 Tablets NDC 80725-620-25 See presoiing nformatio for permeteato 1510 I0°0 (6910 86F) Dosageand Aamiaton 5o USP Contrle Foom et Depes it ACEGEUUETE R e migiconyions Lot Contanet 25 G i ihe P Tablets ik under lge ot Ditby: Supervsion. Dot ke i g. Therefore, it is not available.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.